New Therapy to Treat Type 1 Diabetes Rolls Out Clinical Trial

Type 1 diabetes is an autoimmune condition whereby the person’s own immune system attacks the pancreatic cells that produce insulin. Insulin signals for glucose uptake into cells, a carefully regulated and important process, that when disrupted, can lead to an array of health complications, and without treatment, results in death. Many advances in the care […]

Updates on the Environmental Triggers of Type 1 Diabetes (ADA 2020)

The onset of type 1 diabetes (T1D) usually entails a genetic predisposition to developing the condition, as well as an “environmental trigger” (such as a viral infection, or another exposures). As we previously reported, a multi-center international research effort called TEDDY (The Environmental Determinants of Diabetes in the Young) has been investigating potential environmental triggers […]

New Therapy Shows Promise in Children with Newly-Onset Diabetes (ADA2020)

Research is ongoing around the world concerning the delay of progression and the prevention of type 1 diabetes. The etiology of the disease has been extensively characterized, but all the events and processes that drive and maintain autoimmune attack on the insulin-producing cells are still not fully understood. One avenue of current investigation involves the […]

Age at Type 1 Diabetes Diagnosis Predicts Risk for Other Autoimmune Conditions

It is known that individuals with type 1 diabetes may be more likely than the general population to develop other autoimmune conditions, such as thyroid disorders. The reasons for this are complex, likely multifactorial, and the specific risk factors are still being investigated. Recently, a study sought to evaluate the prevalence of autoimmune disorders in […]